New drug trial aims to protect kidneys in serious lupus complication
NCT ID NCT07201129
Summary
This study is testing whether adding an experimental drug called cenerimod to standard lupus nephritis treatment helps improve kidney function better than standard treatment alone. About 300 adults with active lupus-related kidney inflammation will take either cenerimod or a placebo pill daily for 76 weeks while continuing their regular medications. Researchers will compare kidney test results to see if cenerimod helps reduce protein in urine and maintain kidney filtering ability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allied Biomedical Research Institute
RECRUITINGMiami, Florida, 33155, United States
-
Northwest Houston Arthritis
RECRUITINGHouston, Texas, 77090, United States
-
ProfessionalResearchCenter INC
RECRUITINGMiami, Florida, 33172, United States
-
Rheumatology Care Center, PLLC
RECRUITINGBellaire, Texas, 77401, United States
-
San Marcus Research Clinic, Inc.
RECRUITINGMiami Lakes, Florida, 33014, United States
-
SouthCoast Research Center
RECRUITINGMiami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.